Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-05-25

Clinical Trial Update: Dextenza for Post-operative Treatment of Pterygium [Phase 4]

View source ↗

Summary

Dextenza completed a Phase 4 clinical trial for postoperative treatment of pterygium.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Dextenza (Dexamethasone)

Snippet

Sponsor: Brandon Eye Associates, PA | Conditions: Pterygium of Both Eyes | Phase 4 | Status: COMPLETED